NCT04292977View on ClinicalTrials.gov

Splanchnic and Systemic VLDL-TG and FFA Balance

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

November 15, 2020

Study Completion Date

May 1, 2022

Conditions
NAFLDNASH - Nonalcoholic Steatohepatitis
Trial Locations (1)

8200

Arhus University Hospital Department of Endocrinology and Internal Medicine Skejby, Aarhus N, Denmark, 8200, Skejby

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT04292977 - Splanchnic and Systemic VLDL-TG and FFA Balance | Biotech Hunter | Biotech Hunter